BX Swiss TOP 30 CHF
1.209,99
PKT
+2,65
PKT
+0,22
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
22.10.20 | Nestlé kaufen | DZ BANK | |
22.10.20 | Nestlé buy | UBS AG | |
22.10.20 | Holcim overweight | JP Morgan Chase & Co. | |
22.10.20 | Nestlé Neutral | Credit Suisse Group | |
21.10.20 | Nestlé Underperform | RBC Capital Markets | |
21.10.20 | Nestlé buy | UBS AG | |
21.10.20 | Nestlé overweight | JP Morgan Chase & Co. | |
21.10.20 | UBS buy | Kepler Cheuvreux | |
21.10.20 | Nestlé buy | Goldman Sachs Group Inc. | |
21.10.20 | UBS Hold | Deutsche Bank AG | |
21.10.20 | Novartis overweight | Morgan Stanley | |
21.10.20 | UBS Equal-Weight | Morgan Stanley | |
21.10.20 | Nestlé Underperform | RBC Capital Markets | |
21.10.20 | Nestlé Outperform | Bernstein Research | |
21.10.20 | Nestlé overweight | Barclays Capital | |
21.10.20 | Nestlé add | Baader Bank | |
21.10.20 | UBS Outperform | Credit Suisse Group | |
21.10.20 | Nestlé Hold | Jefferies & Company Inc. | |
21.10.20 | UBS Sector Perform | RBC Capital Markets | |
20.10.20 | UBS overweight | JP Morgan Chase & Co. | |
20.10.20 | UBS Underweight | Barclays Capital | |
20.10.20 | UBS buy | Goldman Sachs Group Inc. | |
20.10.20 | UBS overweight | JP Morgan Chase & Co. | |
20.10.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
19.10.20 | Givaudan buy | UBS AG | |
19.10.20 | Roche overweight | JP Morgan Chase & Co. | |
19.10.20 | UBS Equal weight | Barclays Capital | |
19.10.20 | UBS Underweight | Barclays Capital | |
19.10.20 | UBS buy | Goldman Sachs Group Inc. | |
19.10.20 | UBS buy | Goldman Sachs Group Inc. | |
16.10.20 | UBS Neutral | UBS AG | |
16.10.20 | Roche buy | UBS AG | |
16.10.20 | Roche Outperform | Bernstein Research | |
16.10.20 | Roche Neutral | Credit Suisse Group | |
16.10.20 | Zurich Insurance overweight | Barclays Capital | |
16.10.20 | UBS Outperform | Credit Suisse Group | |
15.10.20 | Roche Hold | Kepler Cheuvreux | |
15.10.20 | Roche buy | UBS AG | |
15.10.20 | Roche buy | Jefferies & Company Inc. | |
15.10.20 | Roche Outperform | Bernstein Research |